An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study
Condition: Dermatomyositis Intervention: Drug: Anti-Beta Interferon (PF-06823859) Sponsor: Pfizer Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials